Why the study?
The quality of antithrombotic therapy in patients with AF after ACS at stage 3 of cardiac rehabilitation needed evaluation.
Answers are grounded in this paper and cite their sources.
In patients with AF after ACS, adherence to antithrombotic therapy guidelines during stage 3 rehabilitation is extremely low, highlighting a critical gap in post-discharge care.
Aim To evaluate the quality of antithrombotic therapy (ATT) in patients with atrial fibrillation (AF) after acute coronary syndrome (ACS) at stage 3 of rehabilitation.Material and methods The registry included 163 patients with AF (mean age, 65.0 [59.0; 72.0] years; 55.8 % men) undergoing rehabilitation after ACS (ACS <1 month ago) in the hospital of the Kirov State Medical University.Results Recommendations for 73.6 % of patients on ATT provided upon discharge from the hospital after stage 2 of rehabilitation were consistent with clinical guidelines (CG). During the entire stage 3, 25.8% of patients had acute cardiovascular complications (CVC) or urgent interventions (8.0% died). Furthermore, the ATT was actually consistent with CG only in 9.2 % of patients; in 21.5 %, errors in changing the ATT timing were detected; and in 84.1 %, various mistakes in the control of international normalized ratio were observed. On the whole, 3.6% of patients incorrectly adjusted their ATT independently, and for 15.3%, the attending physician made incorrect APT adjustments.Conclusion In AF patients after ACS who were undergoing stage 3 of rehabilitation, the quality of the ATT was low despite the recommendations at discharge from the hospital, which depended not only on the patient but also on the attending physician.
No takes yet. Share an insight, caveat, or question.
Tarlovskaya et al. (2022) studied this question.
Synapse has enriched 10 related papers. Consider them for comparative context: